| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ConRes Test Equipment generates approximately $12 million in annual sales and is expected to be immediately accretive to DSG's adjusted EBITDA margins on a go-forward basis.
The transaction will be funded through DSG's existing cash and availability under its credit agreement and is expected to close in the fourth quarter of 2024, subject to customary closing conditions.
This acquisition is not expected to be material for financial reporting purposes to DSG's results.
Posted In: DSGR